Patent Reform Bill Clears House But Damages Provision Remains Contentious Issue
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotechnology Industry Organization President Greenwood opposes provision on damages awards, calling it “infringer-friendly.”
You may also be interested in...
Full House Judiciary Panel Getting Into The Patent Act: IP Issues Will No Longer Go Through Subcmte.
Change in jurisdiction eliminates one round of legislative review, gives Chairman Conyers direct control of issue.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.